Toll-Like Receptors Recognize Intestinal Microbes in Liver Cirrhosis

Establishing or Exaggerating Causality for the Gut Microbiome: Lessons from Human Microbiota-Associated Rodents

(2020) Jens Walter et al.   CELL

Duodenal bacterial load as determined by quantitative polymerase chain reaction in asymptomatic controls, functional gastrointestinal disorders and inflammatory bowel disease

(2020) Ayesha Shah et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Gut-liver axis modulation in fructose-fed mice: a role for PPAR-alpha and linagliptin

(2020) Flávia Maria Silva-Veiga et al.   JOURNAL OF ENDOCRINOLOGY

MyD88-dependent signaling in non-parenchymal cells promotes liver carcinogenesis

(2019) Antje Mohs et al.   CARCINOGENESIS

The gut microbiome and metabolic syndrome

(2019) Kruttika Dabke et al.   JOURNAL OF CLINICAL INVESTIGATION

The Intestinal Microbiome in Nonalcoholic Fatty Liver Disease

(2018) Puneet Puri et al.   Clinics in Liver Disease

Pectin Alleviates High Fat (Lard) Diet-Induced Nonalcoholic Fatty Liver Disease in Mice: Possible Role of Short-Chain Fatty Acids and Gut Microbiota Regulated by Pectin

(2018) Wenfeng Li et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

The role of the gut microbiota in the pathology and prevention of liver disease

(2018) Alejandra Altamirano-Barrera et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Intestinal epithelial Toll-like receptor 4 prevents metabolic syndrome by regulating interactions between microbes and intestinal epithelial cells in mice

(2018) P Lu et al.   Mucosal Immunology

Andrographolide Ameliorates Liver Fibrosis in Mice: Involvement of TLR4/NF-κB and TGF-β1/Smad2 Signaling Pathways

(2018) Liteng Lin et al.   Oxidative Medicine and Cellular Longevity

Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome

(2018) Amandeep Singh et al.   NUTRITION IN CLINICAL PRACTICE

Combining probiotics and an angiotensin‐II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non‐alcoholic steatohepatitis

(2018) Yasuhiko Sawada et al.   HEPATOLOGY RESEARCH

Basic Definitions and Concepts: Organization of the Gut Microbiome

(2017) Eamonn M.M. Quigley   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Gut Microbiota and Complications of Liver Disease

(2017) Chathur Acharya et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Norfloxacin is more effective than Rifaximin in avoiding bacterial translocation in an animal model of cirrhosis

(2017) Isabel Gómez-Hurtado et al.   LIVER INTERNATIONAL

Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention

(2017) Ruixin Liu et al.   NATURE MEDICINE

Gut microbiome as a clinical tool in gastrointestinal disease management: are we there yet?

(2017) Eamonn M. M. Quigley   Nature Reviews Gastroenterology & Hepatology

Systematic Review and Meta-Analysis: Prevalence of Small Intestinal Bacterial Overgrowth in Chronic Liver Disease

(2017) Ayesha Shah et al.   SEMINARS IN LIVER DISEASE

The Human Gut Microbiome in Liver Diseases

(2017) Brian Davis et al.   SEMINARS IN LIVER DISEASE

Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulation

(2017) K. A. Aitbaev et al.   TERAPEVTICHESKII ARKHIV

Parenteral Nutrition-Associated Liver Disease: The Role of the Gut Microbiota

(2017) Monika Cahova et al.   Nutrients

Probiotic Bacillus amyloliquefaciens SC06 Induces Autophagy to Protect against Pathogens in Macrophages

(2017) Yanping Wu et al.   Frontiers in Microbiology

Positive Feedback Regulation between Transglutaminase 2 and Toll-Like Receptor 4 Signaling in Hepatic Stellate Cells Correlates with Liver Fibrosis Post Schistosoma japonicum Infection

(2017) Zhencheng Wen et al.   Frontiers in Immunology

The roles of Toll-like receptor 4 in the pathogenesis of pathogen-associated biliary fibrosis caused by Clonorchis sinensis

(2017) Chao Yan et al.   Scientific Reports

Bile Acids and the Potential Role in Primary Biliary Cirrhosis

(2016) Hang Yang et al.   DIGESTION

Gut microbiome and liver diseases

(2016) Herbert Tilg et al.   GUT

Association of enteric protist Blastocystis spp. and gut microbiota with hepatic encephalopathy

(2016)   Journal of Gastrointestinal and Liver Diseases

Changes in the Microbiome in Cirrhosis and Relationship to Complications: Hepatic Encephalopathy, Spontaneous Bacterial Peritonitis, and Sepsis

(2016) Jatinder Lachar et al.   SEMINARS IN LIVER DISEASE

Cirrhosis and Advanced Fibrosis in Hispanics in Texas: The Dominant Contribution of Central Obesity

(2016) Jingjing Jiao et al.   PLoS One

Alteration of the serum microbiome composition in cirrhotic patients with ascites

(2016) Alba Santiago et al.   Scientific Reports

Fecal Microbiota Transplantation forClostridium difficileInfection

(2015) Dimitri Drekonja et al.   ANNALS OF INTERNAL MEDICINE

Ezetimibe for the treatment of nonalcoholic steatohepatitis: Assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)

(2015) Rohit Loomba et al.   HEPATOLOGY

Mitochondrial dysfunction in steatotic rat livers occurs because a defect in complex i makes the liver susceptible to prolonged cold ischemia

(2015) Michael J. J. Chu et al.   LIVER TRANSPLANTATION

Decompensated cirrhosis and microbiome interpretation

(2015) Jasmohan S. Bajaj et al.   NATURE

Immunomodulating effects of antibiotics used in the prophylaxis of bacterial infections in advanced cirrhosis

(2015) Pedro Zapater   WORLD JOURNAL OF GASTROENTEROLOGY

Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications

(2015) Francesca Romana Ponziani   WORLD JOURNAL OF GASTROENTEROLOGY

Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses

(2014) Zhiyong Ma et al.   Cellular & Molecular Immunology

TLR3/4 signaling is mediated via the NFκB-CXCR4/7 pathway in human alcoholic hepatitis and non-alcoholic steatohepatitis which formed Mallory–Denk bodies

(2014) Hui Liu et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures

(2014) Jasmohan S. Bajaj et al.   HEPATOLOGY

Gut microbiome and nonalcoholic fatty liver diseases

(2014) Lixin Zhu et al.   PEDIATRIC RESEARCH

Impact of psychological stress on irritable bowel syndrome

(2014) Hong-Yan Qin   WORLD JOURNAL OF GASTROENTEROLOGY

Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease

(2014) Kouichi Miura   WORLD JOURNAL OF GASTROENTEROLOGY

Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis

(2013) Yusaku Shirai et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Pathological bacterial translocation in liver cirrhosis

(2013) Reiner Wiest et al.   JOURNAL OF HEPATOLOGY

Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation

(2012) Jasmohan S. Bajaj et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Targeting gut flora to prevent progression of hepatocellular carcinoma

(2012) Marion Darnaud et al.   JOURNAL OF HEPATOLOGY

Effects of enrofloxacin on the human intestinal microbiota in vitro

(2011) Tingtao Chen et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice

(2011) Qiang Zhu et al.   JOURNAL OF HEPATOLOGY

Linking oxidative stress to inflammation: Toll-like receptors

(2010) Roop Gill et al.   FREE RADICAL BIOLOGY AND MEDICINE

Endothelial cell toll-like receptor 4 regulates fibrosis-associated angiogenesis in the liver

(2010) Kumaravelu Jagavelu et al.   HEPATOLOGY

Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion

(2010) Zubin M. Bamboat et al.   JOURNAL OF CLINICAL INVESTIGATION

The normal flora may contribute to the quantitative preponderance of myeloid cells under physiological conditions

(2010) Shi Liang et al.   MEDICAL HYPOTHESES

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

(2010) Taro Kawai et al.   NATURE IMMUNOLOGY

Polyenephosphatidylcholine prevents alcoholic liver disease in PPARα-null mice through attenuation of increases in oxidative stress

(2009) Wataru Okiyama et al.   JOURNAL OF HEPATOLOGY

Probiotics and Liver Disease

(2008) Anish A. Sheth et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY